Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
984.8 INR | +0.01% | +2.05% | +29.68% |
Sales 2024 * | 63.38B 761M | Sales 2025 * | 70.38B 845M | Capitalization | 194B 2.32B |
---|---|---|---|---|---|
Net income 2024 * | 5.95B 71.41M | Net income 2025 * | 7.03B 84.34M | EV / Sales 2024 * | 3.1 x |
Net Debt 2024 * | 2.62B 31.4M | Net cash position 2025 * | 457M 5.49M | EV / Sales 2025 * | 2.74 x |
P/E ratio 2024 * |
32.6
x | P/E ratio 2025 * |
27.6
x | Employees | 14,593 |
Yield 2024 * |
0.9% | Yield 2025 * |
1.02% | Free-Float | 29.28% |
Latest transcript on Alembic Pharmaceuticals Limited
1 day | +0.01% | ||
1 week | +2.05% | ||
Current month | -3.42% | ||
1 month | -4.27% | ||
3 months | +30.39% | ||
6 months | +29.09% | ||
Current year | +29.68% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 83-04-30 | |
Director of Finance/CFO | 64 | 03-01-17 | |
Manisha Saraf
CMP | Compliance Officer | - | 23-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 83-04-30 | |
Director of Finance/CFO | 64 | 03-01-17 | |
Director/Board Member | 56 | 15-02-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 115 M€ | +4.54% | - | |
0.00% | 36 M€ | +4.74% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 984.8 | +0.01% | 141 639 |
24-03-27 | 984.8 | +1.78% | 134,979 |
24-03-26 | 967.5 | +1.05% | 58,691 |
24-03-22 | 957.4 | -0.79% | 51,337 |
24-03-21 | 965 | +2.07% | 209,400 |
Delayed Quote NSE India S.E., March 28, 2024 at 08:01 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.68% | 2.32B | |
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+16.38% | 319B | |
+1.02% | 210B | |
+2.77% | 210B | |
-6.56% | 201B | |
-3.51% | 157B |